DHHC20: A human palmitoyl acyltransferase that causes cellular transformation

Molecular Membrane Biology

Volumn 27, Issue 2-3, 2010, Pages 123-136

  Draper, Jeremiah M ^a   Smith, Charles D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

DHHC; Myristoyl; Palmitoyl acyltransferase; Palmitoylation; Proliferation

Indexed keywords

ACYLTRANSFERASE; MUTANT PROTEIN; PALMITOYL ACYLTRANSFERASE; PROTEIN; PROTEIN DHHC20; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE OVEREXPRESSION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACYLTRANSFERASES; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOYLATION; MICE; NIH 3T3 CELLS; RNA, MESSENGER; TRANSFECTION;

EID: 77950199320     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.3109/09687681003616854     Document Type: Article

References (53)

1. Resh MD. 2006. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006359:re14.
2. Linder ME,Deschenes RJ. 2007. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 81:74-84.
3. Greaves J,Chamberlain LH. 2007. Palmitoylation-dependent protein sorting. J Cell Biol 1763:249-254
4. Milligan G, Parenti M, Magee AI. 1995. The dynamic role of palmitoylation in signal transduction. Trends Biochem Sci 205:181-187.
5. Dudler T,Gelb MH. 1996. Palmitoylation of Ha-Ras facilitates membrane binding, activation of downstream effectors, and meiotic maturation in Xenopus oocytes. J Biol Chem 27119:11541-11547.
6. Mumby SM. 1997. Reversible palmitoylation of signaling proteins. Curr Opin Cell Biol 92:148-154.
7. Kosugi A, Hayashi F, Liddicoat DR, Yasuda K, Saitoh S, Hamaoka T. 2001. A pivotal role of cysteine 3 of Lck tyrosine kinase for localization to glycolipid-enriched microdomains and T cell activation. Immunol Lett 762:133-138.
8. Gelb MH, Brunsveld L, Hrycyna CA, Michaelis S, Tamanoi F, Van Voorhis WC, Waldmann H. 2006. Therapeutic intervention based on protein prenylation and associated modifications. Nat Chem Biol 210:518-528.
9. Resh MD. 1999. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 14511:1-16.
10. Resh MD. 1996. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cell Signal 86:403-412.
11. Hancock JF, Magee AI, Childs JE, Marshall CJ. 1989. All ras proteins are polyisoprenylated but only some are palmitoy-lated. Cell 577:1167-1177.
12. Eungdamrong NJ,Iyengar R. 2007. Compartment-specific feedback loop and regulated trafficking can result in sustained activation of Ras at the Golgi. Biophys J 923:808-815.
13. Pechlivanis M, Kuhlmann J. 2006. Hydrophobic modifications of Ras proteins by isoprenoid groups and fatty acids-more than just membrane anchoring. Biochim Bio-phys Acta 176412:1914-1931.
14. Sandilands E, Brunton VG, Frame MC. 2007. The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endo-some requirements. J Cell Sci 120Pt 15:2555-2564.
15. Downward J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 31:11-22.
16. Shi M, Cooper JC, Yu CL. 2006. A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation. Mol Cancer Res 41:39-45.
17. Leonard DM. 1997. Ras farnesyltransferase: a new therapeutic target. J Med Chem 4019:2971-2990.
18. Chen WJ, Andres DA, Goldstein JL, Russell DW, Brown MS. 1991. cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransfer-ase, the counterpart of yeast DPR1/RAM1. Cell 662: 327-334.
19. Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB. 1993. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 2605116:1934-1937.
20. Lobo S, Greentree WK, Linder ME, Deschenes RJ. 2002. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem 27743:41268-41273.
21. Roth AF, Feng Y, Chen L, Davis NG. 2002. The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J Cell Biol 1591:23-28.
22. Smotrys JE, Schoenfish MJ, Stutz MA, Linder ME. 2005. The vacuolar DHHC-CRD protein Pfa3p is a protein acyl-transferase for Vac8p. J Cell Biol 1707:1091-1099.
23. Valdez-Taubas J, Pelham H. 2005. Swf1-dependent palmi-toylation of the SNARE Tlg1 prevents its ubiquitination and degradation. Embo J 2414:2524-2532.
24. Emmer BT, Souther C, Toriello KM, Olson CL, Epting CL, Engman DM. 2009. Identification of a palmitoyl acyltrans-ferase required for protein sorting to the flagellar membrane. J Cell Sci 122(Pt 6):867-874.
25. Buglino JA, Resh MD. 2008. Hhat is a palmitoylacyltrans-ferase with specificity for N-palmitoylation of Sonic Hedgehog. J Biol Chem 28332:22076-22088.
26. Fernandez-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, Bredt DS, Sessa WC. 2006. Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 1743:369-377.
27. FukataM, Fukata Y, Adesnik H, Nicoll RA, Bredt DS. 2004. Identification of PSD-95 palmitoylating enzymes. Neuron 446:987-996.
28. Ducker CE, Stettler EM, French KJ, Upson JJ, Smith CD. 2004. Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase. Oncogene 2357: 9230-9237.
29. Swarthout JT, Lobo S, Farh L, Croke MR, Greentree WK, Deschenes RJ, Linder ME. 2005. DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-Ras. J Biol Chem 28035: 31141-31148.
30. Sharma C, Yang XH, Hemler ME. 2008. DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol Biol Cell 19:3415-3425.
31. Zhang J, Planey SL, Ceballos C, Stevens SM, Jr., Keay SK, Zacharias DA. 2008. Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics 77:1378-1388.
32. Dunphy JT, Greentree WK, Manahan CL, Linder ME. 1996. G-protein palmitoyltransferase activity is enriched in plasma membranes. J Biol Chem 27112:7154-7159.
33. Liu L, Dudler T, Gelb MH. 1996. Purification of a protein palmitoyltransferase that acts on H-Ras protein and on a C-terminal N-Ras peptide. J Biol Chem 27138: 23269-23276.
34. Draper JM, Xia Z, Smith CD. 2007. Cellular palmitoylation and trafficking of lipidated peptides. J Lipid Res 488: 1873-1884.
35. Hou H, Subramanian K, LaGrassa TJ, Markgraf D, Dietrich LE, Urban J, Decker N, Ungermann C. 2005. The DHHC protein Pfa3 affects vacuole-associated palmi-toylation of the fusion factor Vac8. Proc Natl Acad Sci USA 10248:17366-17371.
36. Ohno Y, Kihara A, Sano T, Igarashi Y. 2006. Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Bio-chim Biophys Acta 17614:474-483.
37. Varner AS, Ducker CE, Xia Z, Zhuang Y, De Vos ML, Smith CD. 2003. Characterization of human palmitoyl-acyl transferase activity using peptides that mimic distinct palmi-toylation motifs. Biochem J 373(Pt 1): 91-99.
38. Varner AS, De Vos ML, Creaser SP, Peterson BR, Smith CD. 2002. A fluorescence-based high performance liquid chromatographic method for the characterization of palmitoyl acyl transferase activity. Anal Biochem 3081: 160-167.
39. Schroeder H, Leventis R, Shahinian S, Walton PA, Silvius JR. 1996. Lipid-modified, cysteinyl-containing pep-tides of diverse structures are efficiently S-acylated at the plasma membrane of mammalian cells. J Cell Biol 1343: 647-660.
40. Creaser SP, Peterson BR. 2002. Sensitive and rapid analysis of protein palmitoylation with a synthetic cell-permeable mimic of SRC oncoproteins. J Am Chem Soc 12411: 2444-2445.
41. Peters C, Wagner M, Volkert M, Waldmann H. 2002. Bridging the gap between cell biology and organic chemistry: chemical synthesis and biological application of lipidated peptides and proteins. Naturwissenschaften 899: 381-390.
42. Ducker CE, Griffel LK, Smith RA, Keller SN, Zhuang Y, Xia Z, Diller JD, Smith CD. 2006. Discovery and characterization of inhibitors of human palmitoyl acyltransferases. Mol Cancer Ther 57:1647-1659.
43. Shalloway D, Coussens PM, Yaciuk P. 1984. Overexpression of the c-src protein does not induce transformation of NIH 3T3 cells. Proc Natl Acad Sci USA 8122:7071-7075.
44. Tao WJ, Lin H, Sun T, Samanta AK, Arlinghaus R. 2008. BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor. Oncogene 2722: 3194-3200.
45. Meyn MA, 3rd, Wilson MB, Abdi FA, Fahey N, Schiavone AP, Wu J, Hochrein JM, Engen JR, Smithgall TE. 2006. Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity. J Biol Chem 28141:30907-30916.
46. Pecquet C, Nyga R, Penard-Lacronique V, Smithgall TE, Murakami H, Regnier A, Lassoued K, Gouilleux F. 2007. The Src tyrosine kinase Hck is required for Tel-Abl-but not for Tel-Jak2-induced cell transformation. Oncogene 2611:1577-1585.
47. Thomas SM, Brugge JS. 1997. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13:513-609.
48. Belsches-Jablonski AP, Biscardi JS, Peavy DR, Tice DA, Romney DA, Parsons SJ. 2001. Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene 2012:1465-1475.
49. Reissig D, Clement J, Sanger J, Berndt A, Kosmehl H, Bohmer FD. 2001. Elevated activity and expression of Src-family kinases in human breast carcinoma tissue versus matched non-tumor tissue. J Cancer Res Clin Oncol 1274:226-230.
50. Han NM, Curley SA, Gallick GE. 1996. Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases. Clin Cancer Res 28: 1397-1404.
51. Nakamura K, Chijiiwa Y, Nawata H. 1996. Augmented expression of LCK message directed from the downstream promoter in human colorectal cancer specimens. Eur J Cancer 32A8:1401-1407.
52. Park J, Meisler AI, Cartwright CA. 1993. c-Yes tyrosine kinase activity in human colon carcinoma. Oncogene 810:2627-2635.
53. Veillette A, Foss FM, Sausville EA, Bolen JB, Rosen N. 1987. Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell lines. Oncogene Res 14:357-374.